InvestorsHub Logo
Post# of 252865
Next 10
Followers 0
Posts 253
Boards Moderated 0
Alias Born 03/01/2006

Re: rkrw post# 126817

Monday, 09/19/2011 4:40:01 PM

Monday, September 19, 2011 4:40:01 PM

Post# of 252865

I'll go on record and predict a Novartis munch within 12 months. Cash+CVR's for Copaxone.



If so, it may help explain why NVS has declined to partner with MNTA on FOB, if in fact they think it has value. Why drive the buyout price up?
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.